Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-17-049664

SVP & Chief Medical Officer sold 1,997 shares at $19.32 ($38,582)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gergel Ivan P. SVP & Chief Medical Officer 2017-08-16 Sale −1,997 $19.32 $38,582 41,575 D: show line 1 in the form
Open-market sales · 1,997 sh · avg $19.32 · $38,582
Loading xslF345X03/doc4.xml…